Revolutionary Technology
Building the future of personalized diagnostics and disease-modifying therapies
designed to work in concert with the immune system
Driven Minds
Our highly motivated team of scientists and collaborators are developing
novel immunotherapies and diagnostics for patients with autoimmune diseases
Precise Execution
Our approach to precision medicine combines pioneering
scientific insights with novel analytics, therapeutics and diagnostics
Patient Focused
Our clinical development programs are designed to
address the needs of patients with autoimmune diseases
About ImmusanT

At ImmusanT, we are developing a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Our Epitope-Specific Immuno-Therapy™ (ESIT™) platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. Our lead program, Nexvax2®, is in clinical development with the goal of protecting celiac disease patients against the debilitating effects of gluten.

We are now recruiting for the Phase 2 RESET CeD clinical trial of Nexvax2 in celiac disease.

One Kendall Square
Building 700
Cambridge, MA 02139
Phone: 617-299-8399